The aim of the present study was to evaluate the protective effects of blueberry extract on oxidative stress and inflammatory parameters in a model of mania induced by ketamine administration in rats. Male rats were pretreated with blueberry extract (200 mg/kg, once a day for 14 days), lithium chloride (45 mg/kg, mood stabilizer used as a positive control, twice a day for 14 days), or vehicle. Between the 8th and 14th days, rats also received an injection of ketamine (25 mg/kg) or vehicle. In the 15th day, thirty minutes after ketamine administration the hyperlocomotion of the animals was assessed in the open -field apparatus. Immediately after the behavioral analysis brain and blood were collected for biochemical determinations. ketamine treatment induced hyperlocomotion and oxidative damage in cerebral cortex, hippocampus and striatum such as an increase in lipid peroxidation and a decrease in the antioxidant enzymes activities (superoxide dismutase, catalase e glutatione peroxidase). Ketamine administration also increased the IL-6 levels in serum in rats. Pretreatment of rats with blueberry extract or lithium prevented the hyperlocomotion, pro -oxidant effects and inflammation induced by ketamine. Our findings suggest that blueberry consumption has a neuroprotective potential against behavioral and biochemical dysfunctions induced in a preclinical model that mimic some aspects of the manic behavior.
Introduction
Bipolar disorder (BD) is a chronic, severe and prevalent mental disorder associated with high rates of non-recovery, recurrence, development and progression of psychiatric disorders, including BD (Berk et al., 2011; Bauer et al., 2014; Selek et al., 2015) .
Oxidative stress occurs when there is an imbalance between pro-oxidant levels and antioxidant capacity (Jones, 2008) . This condition can contribute to damage in cellular components, such as proteins, lipids and DNA, leading to apoptosis and cell death (Jones, 2008) . The brain is especially vulnerable to the effects of oxidative stress because of its high oxygen demand and its high amounts lipids susceptible to peroxidation . In this line, oxidative stress is thought to mediate neuropathological processes associated with progression of BD (Selek et al., 2015) . In addition, several pieces of evidences demonstrated increased pro inflammatory mediators, such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF␣) in BD, suggesting that activation in inflammatory pathways is also involved in this pathology (Modabbernia et al., 2013; Bauer et al., 2014; Selek et al., 2015) .
Mood stabilizers such as lithium represent the first line of treatment during a manic episode. However, many BD patients do not adequately respond to pharmacological treatment and frequently present some side effects that contribute to reduce the patients' quality of life (Budni et al., 2013) . Therefore, it is important to search for new therapeutic approaches that represent alternative strategies to manage the mood episodes associated with BD. In fact, there is a growing interest in the use of natural compounds with antioxidant and anti-inflammatory properties such as polyphenol-rich fruit extracts (Nardi et al., 2016) .
Blueberries are plants belonging to genus Vaccinium of the family Ericaceae (Nardi et al., 2016) . The fruit has a dark color due to the presence of anthocyanins as principal pigment. Studies have described a wide range of biological properties and several health benefits might be associated with the consumption of blueberry, such as high antioxidant capacity, anti-inflammatory, immune-regulatory and neuroprotective properties (Wang et al., 2013; Kšonžeková et al., 2016; Nardi et al., 2016) . Evidences have demonstrated also the association between regular blueberry consumption and the clinical improvement in neurodegenerative disorders, such as Alzheimer's and Parkinson's disease (Subash et al., 2014) . Nevertheless, the effects of the blueberry consumption in behavior associated with psychiatric disorders are not elucidated yet.
Data from literature have demonstrated alterations in hippocampus and cerebral cortex in BD such as reduction of synapsin (Vawter et al., 2002) , decreased hippocampal NMDA receptors (Scarr et al., 2003) , and decreased cortical thickness (Lyoo et al., 2006) . These two structures have been associated with a progressive decline of density and volume in patients with multiple mood episodes (Strakowski et al., 2002; Roda et al., 2015) . In addition, striatum dysfunctions also have often been suggested due to its functional importance as a relay station integrating information between cortical areas and the thalamus (Marchand and YurgelunTodd, 2010) . In this context, the aim of this study was to evaluate the neuroproctetive effects of blueberry extract (Vaccinium virgatum) on oxidative stress parameters in cerebral cortex, hippocampus and striatum and peripheral inflammation in rats submitted to a model of manic-like behavior induced by ketamine.
Materials and methods

Animals
Male Wistar rats (60 days old) were obtained from the Central Animal House of the Federal University of Pelotas, Pelotas, RS, Brazil. Animals were maintained on a 12/12 h light/dark cycle in an air-conditioned constant temperature (22 ± 1 • C) colony room. Rats had free access to a 20% (w/w) protein commercial chow and Bordignon et al. (2009) with modifications. Briefly, unprocessed frozen blueberry fruits (30 g) were sonicated for 30 min at 25 • C in 90 mL 70:30 v/v ethanolwater. The pH solution was adjusted to 1.0. After this, the crude extracts were filtered; the ethanol evaporated under reduced pressure and the remaining aqueous solution was lyophilized yielding the test samples. These procedures were performed in triplicate and sheltered from light.
Total flavonoid content
The total flavonoid content in samples was determined according to Miliauskas et al. (2004) with minor modifications. The calibration curve was prepared by mixing aliquots of 1 mL of an ethanolic solution of rutin at concentrations of 100, 150, 200, 300, 450 and 500 g/mL with 1 mL of an ethanolic solution of 20 g/L aluminum chloride and diluted to 25 mL of ethanol. The absorptions were measured at 415 nm after 40 min. These readings were used to draw the calibration curve. The absorption of each blueberry sample was measured under the same conditions. Data are mean ± SD values expressed as milligrams of rutin per 1 g of dried extract. All analyses were performed in triplicate.
Total phenolic content
The total phenolic content was determined according to Singleton et al. (1999) with slight modifications. The calibration curve was first prepared by mixing 125 mL aliquots of an ethanolic solution of gallic acid at concentrations of 100, 150, 200, 300, 450 and 500 g/mL, 500 L of distilled water and 125 L of FolinCiocalteau reagent. After 3 min 1.25 mL of a 7% solution of sodium carbonate was added and 1 mL of distilled water making a final volume of 3 mL. The readings were performed after 90 min on a wavelength of 760 nm. Data are mean ± SD values expressed as milligrams of gallic acid per 1 g of dried extract.
Total anthocyanin content
Anthocyanins were quantified by the differential pH method. Calculation of the anthocyanin concentration was based on cyanidin-3-glucoside in a molar extinction coefficient of 26,900 and molecular weight of 449.2 g/mol. Data are mean ± SD values expressed as milligrams of cyanidin-3-glucoside per 1 g of dried extract. All analyses were performed in triplicate.
LC/MS and anthocyanin identification
Anthocyanin profile analysis was performed by liquid chromatography (UPLC, Waters Acquity mode) coupled to high resolution mass spectrometry (Xevo G2 QTof model), equipped with an electrospray ionization source and controlled by MassLynx v.4.1 software. Separation was performed in a C18 column (100 × 2.1 mm-1.7 uM − Kinetix/Phemomenex) at 40 • C. The mobile phase consisted of a linear gradient of 0.1% formic acid (A) and acetonitrile (B) using the range of 5%-58% B over 8 min at a flow rate of 0.5 mL min −1 . A mass spectrum was obtained in positive mode, with a mass range of m/z of 100 to 1000. The capillary voltage used was 2.0 kV and the cone voltage of 50 V. Nebulization and desolvation were performed with nitrogen at 300 and flow 10 L h −1 .
Desolvation and source temperature were respectively 300 • C and 120 • C.
Experimental protocol of mania state and treatment with blueberry extract
This study was designed to mimic the prevention protocol of the mania state as previously described in the literature (Ghedim et al., 2012; Gazal et al., 2014) . The animals were divided into six groups: saline/saline, saline/blueberry extract (200 mg/kg)/, saline/lithium chloride (45 mg/kg × 2 per day), ketamine/saline, ketamine/blueberry extract (200 mg/kg), ketamine/lithium chloride (45 mg/kg × 2 per day). The experimental groups were treated with blueberry extract 200 mg/kg (once a day) and lithium 45 mg/kg (twice a day) for 14 days by oral administration. From the 8th to the 14th day the animals also received saline or ketamine (25 mg/kg) once a day by intraperitoneal route administration. On the 15th day of treatment, the animals received a single injection of ketamine or saline and the locomotor activity was assessed in the open-field apparatus after 30 min (Fig. 1) . Ketamine, blueberry extracts and lithium chloride were dissolved in saline solution (NaCl 0.9%). The doses of ketamine, lithium chloride and blueberry extract used in the present study were chosen according to the literature (Ghedim et al., 2012; Gazal et al., 2014; Gutierres et al., 2014a) .
Open-field test
Locomotor and anxiety-related behavior was monitored using an open-field apparatus, as previously described (Gazal et al., 2014) . The apparatus consisted of a wooden box measuring 72 × 72 × 33 cm cm. The floor of the arena was divided into 16 equal squares (18 × 18 cm) and placed in a sound free room. Animals were placed in the rear left square and left to explore it freely for 5 min. The total number of squares crossed with all paws (crossing) was manually counted in order to evaluate the ambulatory behavior. The apparatus was cleaned with a 10% alcohol solution and dried after each individual animal session.
Determination of oxidative stress parameters in brain structures
Rats were submitted to euthanasia immediately after the open-field test. Cerebral cortex, hippocampus and striatum were homogenized in 10 vol (1:10 w/v) of 20 mM sodium phosphate buffer, pH 7.4 containing 140 mM KCl. Homogenates were centrifuged at 750 x g for 10 min at 4 • C, the pellet was discarded and the supernatant was immediately separated and used for the oxidative stress measurements. The protein content was quantified using bovine serum albumin as a standard.
Thiobarbituric acid reactive species formation (TBARS)
The measure of lipid peroxidation was determined by TBARS in accordance with the protocol described by Esterbauer and Cheeseman (1990) . Briefly, homogenates were mixed with trichloroacetic acid 10% and thiobarbituric acid 0.67% and heated in a boiling water bath for 25 min. TBARS was determined by the absorbance at 535 nm. Results were reported as nmol of TBARS per mg of protein.
Total sulfhydryl content (SH content)
This assay was performed as described by Aksenov and Markesbery (2001) which is based on the reduction of DTNB by thiols, which in turn, becomes oxidized (disulfide) generating a yellow derivative (TNB) whose absorption is measured spectrophotometrically at 412 nm. Briefly, homogenates were added to PBS buffer pH 7.4 containing EDTA. The reaction was started by the addition of 5,5 -dithio-bis(2-nitrobenzoic acid) (DTNB). Results were reported as mol TNB per mg of protein.
Catalase (CAT) assay
CAT activity was assayed by the method of Aebi (1984) . H 2 O 2 disappearance was continuously monitored during 90 s in a spectrophotometer adjusted at 240 nm. CAT specific activity was reported as units of enzyme per mg of protein.
Superoxide dismutase (SOD) assay
Total SOD activity was measured using the method described by Misra and Fridovich (1972) . This method is based on the inhibition of superoxide dependent adrenaline auto-oxidation in a spectrophotometer adjusted at 480 nm. The specific activity of SOD was reported as units per mg of protein.
Glutathione peroxidase (GPx)
GPx activity was measured according to the method described by Wendel (1981) using tert-butyl hydroperoxide as substrate. NADPH disappearance was monitored spectrophotometrically at 340 nm in a medium containing 2 mM glutathione, 0.15 U/mL glutathione reductase, 0.4 mM azide, 0.5 mM tert-butyl hydroperoxide and 0.1 mM NADPH. One GPx unit is defined as 1 mol of NADPH consumed per minute and the specific activity is represented as units/mg of protein.
Cytokine analysis
Serum levels of IL-6 and IL-10 were measured using Immunoassay kits (DuoSet ELISA Development, R&D Systems, Inc., USA) according to the manufacturer's instructions. The presence and concentration of the cytokines were determined by the intensity of the color measured by spectrometry in a micro ELISA reader.
Statistical analysis
Comparisons between experimental groups were performed by two-way analysis of variance (ANOVA) followed by Bonferroni posthoc test. The values are expressed as mean ± S.E.M. P < 0.05 was considered significant.
Results
Total anthocyanin content in blueberry was 13.03 ± 0.44 mg/g of dried extract. As to the total flavonoid content, 156.52 ± 4.86 mg/g of dried extract were detected. In addition, the total phenolic content was 302.70 ± 8.13 mg/g of dried extract.
Anthocyanin identification was based on fragmentation pattern and exact mass (Table 1) . Five aglycone fragments, cyanidin (m/z 287.0552), peonidin (m/z 301.0711), delphinidin (m/z 303.0506), petunidin (m/z 317.0668) and malvidin (m/z 331.0814) were identified. Aglycone fragmentation pattern and exact mass allowed the identification of nine monoglucosylated anthocyanins.
Ketamine treatment induced hyperlocomotion in rats, which was evaluated by an increase in the number of crossings in the open field test (Fig. 2) . Pretreatment with blueberry extract or lithium prevented the hyperlocomotion induced by ketamine: blueberry and lithium pretreatment: [F(2,44) = 7.18 P = 0.0020], ketamine treatment: [F(1,44) = 29.07 P = 0.0001], interaction: [F(2,44) = 3.32 P = 0.0450] (Fig. 2) .
The results of oxidative stress parameters in cerebral cortex are demonstrated in Fig. 3 . Our results showed that treatment with ketamine caused an increase in the TBARS levels in cerebral cortex and pretreatment with blueberry extract or lithium was able to prevent this effect ketamine treatment: [F(2,26) = 3.55 (Fig. 3A) . Blueberry extract and lithium pretreatment also prevented the decrease in the total sulfhydryl content induced by ketamine in cerebral cortex (ketamine treatment: [F(2,23) = 5.46 P = 0.0285], blueberry and lithium pretreatment: [F(1,23) = 11.4 P = 0.0004] interaction: [F(2,23) = 42.54 P < 0.0001]) (Fig. 3B) . In relation to antioxidant enzymes we observed a decrease in the SOD and CAT activities in cerebral cortex of rats treated with ketamine. In addition, blueberry and lithium were capable of preventing this effect: (SOD: ketamine treatment: [F(2,23) = 12.14 P = 0.0022], blueberry and lithium pre- (Fig. 3D) . No changes were observed in the activity of GPx in cerebral cortex in all groups evaluated in this study (Fig. 3E) . (Fig. 4D) . No changes were observed in the levels of total sulfhydryl content and activity of GPx in hippocampus in all groups evaluated in this study ( Fig. 4B and E) .
As demonstrated in (Fig. 5E ). As demonstrated in Fig. 5B -D, no changes were observed in the levels of total sulfhydryl content and activity of SOD and CAT enzymes in striatum in all groups of this study (Fig. 5B-D) .
In this study we also evaluated the effects of blueberry extract and lithium on inflammatory parameters such as IL-6 and IL-10 levels in a ketamine − induced model of mania. Our results showed that ketamine induced an increase in serum IL-6 levels and that only lithium treatment was capable of preventing this alteration: (ketamine treatment: [F(1,18) = 5.48 P< 0.0001], lithium pretreatment: [F(2,18) = 9.95 P = 0.0014], interaction: [F(2,18) = 27.04 P = 0.0316]) (Fig. 6A) . No changes were observed in the IL-10 levels in serum in any of the groups evaluated in this study (Fig. 6B ).
Discussion
In the present study we evaluated the effects of blueberry extract in an experimental model of manic-like behavior induced by ketamine administration in rats. Ketamine is a psychotomimetic compound also used as an anesthetic drug. In sub anesthetic doses ketamine is able to induce different effects on mood and behavior, ranging from a fast antidepressant effect (in lower doses) to induction of hyperlocomotion and manic-like behavior (in higher sub anesthesic doses) (Ghedim et al., 2012) . Ketamine is a pharma- ; and glutathione peroxidase activity (E) in hippocampus of animals submitted to ketamine-induced manic-like behavior. Data were expressed as mean ± S.E.M. **Denotes P < 0.01 as compared to the vehicle/saline group. # Denotes P < 0.05 and ## P < 0.01 as compared to vehicle/ketamine group. (Two way ANOVA followed by Bonferroni post hoc test, n = 5-6).
cological antagonist of NMDA glutamate receptors, and represents a valid model of manic-like behavior because this model produces behavioral and biochemical alterations such as hyperlocomotion, oxidative stress and changes in levels of brain-derived neurotrophic factor similar to those found in BD (Ghedim et al., 2012; Fraga et al., 2013; Gazal et al., 2014) . Others studies have demonstrated that ketamine impairs mitochondrial function interfering with the complex I activity, resulting in impaired oxidative phosphorylation efficiency and increased mitochondrial nitric oxide synthase (mitNOS) activity leading to increased levels of superoxide (O 2
•− ) and nitric oxide (NO) (Venâncio et al., 2015) . Ito et al., 2015 also demonstrated that ketamine induce reactive species generation and apoptosis in human neurons. Considering that preclinical studies demonstrated that glutamatergic system abnormalities are involved in the pathophysiology of BD and that conventional mood stabilizer, such as lithium, prevent behavioral and biochemical alterations observed in ketamine-treated animals, studies suggest the face and predictive validities of this animal model for investigate mechanisms related to BD (Ghedim et al., 2012; Gazal et al., 2014) Our findings showed that ketamine administration induced hyperlocomotion and changes in some brain oxidative stress parameters such as the increase in TBARS levels, decrease in the total thiol content in cerebral cortex and decrease in the activities ) pretreatment on levels of TBARS (A); total thiol content (B); superoxide dismutase activity (C); catalase activity (D); and glutathione peroxidase activity (E) in striatum of animals submitted to ketamine-induced manic-like behavior. Data were expressed as mean ± S.E.M. *Denotes P < 0.05 as compared to the vehicle/saline group. *Denotes P < 0.05 and ## P < 0.01 as compared to vehicle/ketamine group. (Two way ANOVA followed by Bonferroni post hoc test, n = 5-6).
of antioxidant enzymes SOD and CAT (cerebral cortex and hippocampus) and GPX (striatum). Similar results were described in other studies with experimental models of mania (Jornada et al., 2011; Gazal et al., 2014) . In addition, the literature has consistently reported increased products of lipid peroxidation and alterations in antioxidant enzymes in serum, plasma and red blood cells of the BD patients (Ranjekar et al., 2003; Machado-Viera et al., 2007; Andreazza et al., 2008; Kapczinski et al., 2011) .
Lipid peroxidation is the one the main events induced by oxidative stress in which reactive species interact with polyunsaturated fatty acids (Ayala et al., 2014) . Oxidation products may induce damage to cellular membrane components, alterations in the biochemical properties of biomolecules, cell necrosis and inflammation (Leutner et al., 2001; Stark, 2005; Montine et al., 2002; Rawdin et al., 2013; Ayala et al., 2014) . Antioxidant enzymes such as SOD, CAT and GPx have a crucial role in the scavenging free radicals. CAT and SOD catalyzes the dismutation of superoxide anion (O 2
•− ) in hydrogen peroxide (H 2 O 2 ) which is sequentially degraded by CAT and GPx enzymes (Pisoschi and Pop, 2015) . A decrease in the activity of SOD, CAT and GPx enzymes may lead to an excess of O 2 •− and H 2 O 2 which in turn generates hydroxyl radicals, resulting in initiation and propagation of lipid peroxidation (Matés et al., 1999; Leutner et al., 2001; Pisoschi and Pop, 2015) . The results of this study suggest that the imbalance in antioxidant defenses probably alters reactive species elimination increasing the amount of free radicals. In this line, it is plausible to suggest that the oxidative stress is associated with changes in brain structures involved in mood and emotional regulation during the manic phase of BD (Andreazza et al., 2008; Berk et al., 2011) . The main finding of this study was the ability of blueberry extract to prevent hyperlocomotion and changes in oxidative stress parameters induced by ketamine in rats. These results are consistent with other experimental conditions, where blueberry treatment improved antioxidant defenses and decreased oxidant agents in brain regions (Papandreou et al., 2009; Pang et al., 2010; Ç oban et al., 2013; Carvalho et al., 2015 Carvalho et al., , 2016 .
Blueberries are the fruits that contain several polyphenolic compounds such as flavonoids, nonflavonoids and phenolic acids. Anthocyanins, a subset of flavonoids, are particularly abundant and play an important role in the protective effect of blueberries. In fact, the antioxidant effects of anthocyanins has been attributed to their metal chelating activities (Han et al., 2015) , modulation of antioxidant enzymes (Carvalho et al., 2015) , capacity to scavenge free radicals (Peng et al., 2014) and ability to decrease the activation of nuclear factor NF-K ␤ (Karlsen et al., 2007) . The neuroprotective effect of anthocyanins can be related also to this capacity to cross the blood-brain barrier acting in specific regions of the brain (Subash et al., 2014) .
Previous studies from our research group have demonstrated that anthocyanin-rich extract prevented impairment of memory and anxiogenic behavior in an experimental model of Alzheimer (Gutierres et al., 2014a,b) . In addition, it has been demonstrated that anthocyanins have affinity for GABA A receptors, since they are capable to displace the specific binding of [ 3 H] flunitrazepam to benzodiazepinic site of these receptors (Gutierres et al., 2014a) . Anthocyanin treatment can also regulate ion pump activity, cholinergic neurotransmission (Gutierres et al., 2014a,b) , attenuate the generation of ROS, reduce the production of proinflammatory cytokines and prevent the increase of myeloperoxidase activity in the brain (Carvalho et al., 2015) . Moreover, another study demonstrated that anthocyanins prevented infiltration of peripheral immune cells in the hippocampus and reduced microglia (Iba-1) and astrocyte (GFAP) immunoreactivity after lipopolysaccharide administration in mice (Carvalho et al., 2016) .
Considering that several polyphenolic compounds present in blueberry extract, especially anthocyanins, have many cellular targets, blueberry is a promising neuroprotective compound that might be useful against brain dysfunctions associated with BD, especially during the manic episode. Although we cannot precisely explain the mechanisms involved in the effect of blueberry in ketamine − induced hyperlocomotion, there is a strong possibility that blueberry and lithium might share some of the intracellular targets to exert their antimaniac effects. However, is important to note that this antimaniac effect of blueberry can be associated with antioxidant effects observed in this study.
Another important aspect to be discussed is that similar results were observed between blueberry and lithium treatment in oxidative stress parameters in hippocampus and cerebral cortex. Lithium is recommended as a first -line treatment for bipolar disorders. This drug is a gold standard mood stabilizing agent that has been found to prevent and/or reverse the oxidative stress parameters in experimental models and in BD patients (Jornada et al., 2011; Banerjee et al., 2012; Sousa et al., 2014; Gazal et al., 2014) . However, lithium treatment has also been associated with several side effects (Honig et al., 1999; Henry, 2002) . In this line we can suggest that blueberry consumption is a natural and promising compound that should be better investigated in future studies with the aim of finding better therapeutical agent to benefit patients with bipolar disorders in manic phase.
In this study we also showed increase in serum IL-6 levels in rats after ketamine administration. Several studies have reported increased levels of circulating proinflammatory cytokines in different phases of BD (Munner, 2016) . Increased levels of IL-6 have been consistently described in manic episodes Kunz et al., 2011; Ozdemircan et al., 2015) . Inflammation and oxidative stress are connected in both physiological as well as in pathological conditions. In fact, data from literature have reported that ROS production stimulates the synthesis and release of IL-6 by activation of transcriptional factors through the NF-KB dependent pathway (Kosmidou et al., 2002) . Our findings are consistent with the hypothesis that mechanisms regulating inflammation and oxidation are dysregulated in the manic phase of BD. Indeed, several studies demonstrated a connection between oxidative stress, proinflammatory conditions and neuroprogression of BD, leading to brain dysfunctions associated to increase in symptoms' severity and higher number of episodes over the course of disease (Berk et al., 2011; Bauer et al., 2014) .
Lithium pretreatment was capable to prevent the alterations in IL-6 levels induced by ketamine. These results are in accordance with the literature data, showing that decreased levels of this cytokine are associated with lithium therapy in BD patients (Boufidou et al., 2004; Kim et al., 2007; Brietzke et al., 2009 ). The action mechanisms underlying the efficacy of lithium have not been completely elucidated, and some authors have suggested that this mood stabilizer also plays a role in inflammatory pathways, attenuating IL-6 production (Nassar and Azab, 2014) . Even though blueberry has been associated with anti-inflammatory properties in others studies, we did not observe any significant differences in the levels of IL-6 induced by ketamine. The peripheral levels of the anti-inflammatory cytokine IL-10 were changed neither by ketamine nor by blueberry treatment.
Our findings support the hypothesis that oxidative stress and increased levels of IL-6 might contribute for biochemical and behavioral dysfunctions associated with bipolar disorder during manic episodes. Blueberry prevented changes in oxidative stress parameters induced by ketamine. These results are very important from the translational point of view because they reinforce the benefits of natural compounds to the health, in special in the progression and complications associated to oxidative stress in BD.
